Detalles de la búsqueda
1.
Dendritic cells can prime anti-tumor CD8+ T cell responses through major histocompatibility complex cross-dressing.
Immunity;
55(6): 982-997.e8, 2022 06 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35617964
2.
Dendritic cells can prime anti-tumor CD8+ T cell responses through major histocompatibility complex cross-dressing.
Immunity;
55(11): 2206-2208, 2022 Nov 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36351377
3.
Wild-Type U2AF1 Antagonizes the Splicing Program Characteristic of U2AF1-Mutant Tumors and Is Required for Cell Survival.
PLoS Genet;
12(10): e1006384, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27776121
4.
Loss of 5-hydroxymethylcytosine expression is near-universal in B-cell lymphomas with variable mutations in epigenetic regulators.
Haematologica;
107(4): 966-969, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34911281
5.
T-cell States, Repertoire, and Function in Classical Hodgkin Lymphoma Revealed through Single-Cell Analyses.
Cancer Immunol Res;
12(3): 296-307, 2024 03 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38240659
6.
CD5 Gene Signature Identifies Diffuse Large B-Cell Lymphomas Sensitive to Bruton's Tyrosine Kinase Inhibition.
J Clin Oncol;
42(4): 467-480, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38079587
7.
Integrative genomic analysis identifies unique immune environments associated with immunotherapy response in diffuse large B cell lymphoma.
bioRxiv;
2024 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38328071
8.
Pembrolizumab for the treatment of disease relapse after allogeneic hematopoietic stem cell transplantation.
Blood Adv;
7(6): 963-970, 2023 03 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35973200
9.
TIGIT is a key inhibitory checkpoint receptor in lymphoma.
J Immunother Cancer;
11(6)2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37364933
10.
Efficacy of checkpoint inhibition after CAR-T failure in aggressive B-cell lymphomas: outcomes from 15 US institutions.
Blood Adv;
7(16): 4528-4538, 2023 08 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37026796
11.
Checkpoint Blockade-Induced Dermatitis and Colitis Are Dominated by Tissue-Resident Memory T Cells and Th1/Tc1 Cytokines.
Cancer Immunol Res;
10(10): 1167-1174, 2022 10 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35977003
12.
Quantitative tissue analysis and role of myeloid cells in non-small cell lung cancer.
J Immunother Cancer;
10(7)2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35793873
13.
Antibody and T cell responses to COVID-19 vaccination in patients receiving anticancer therapies.
J Immunother Cancer;
10(6)2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35732350
14.
Severe COVID-19 induces autoantibodies against angiotensin II that correlate with blood pressure dysregulation and disease severity.
Sci Adv;
8(40): eabn3777, 2022 10 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36206332
15.
Lymphatic coagulation and neutrophil extracellular traps in lung-draining lymph nodes of COVID-19 decedents.
Blood Adv;
6(24): 6249-6262, 2022 12 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-35977099
16.
Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma.
J Immunother Cancer;
9(9)2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34593622
17.
Brachytherapy and non-cancer mortality in patients with oral cavity and oropharynx SCCs.
Oral Oncol;
122: 105585, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34688055
18.
SARS-CoV-2 infection induces cross-reactive autoantibodies against angiotensin II.
medRxiv;
2021 Nov 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34751272
19.
Severe COVID-19 infection is associated with aberrant cytokine production by infected lung epithelial cells rather than by systemic immune dysfunction.
Res Sq;
2021 Nov 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34845442
20.
COVIDOSE: A Phase II Clinical Trial of Low-Dose Tocilizumab in the Treatment of Noncritical COVID-19 Pneumonia.
Clin Pharmacol Ther;
109(3): 688-696, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33210302